TransMedics Group Inc (TMDX)

Exchange
NASDAQ
Symbol
TMDX
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    60.00
  • High
    62.50
  • Low
    59.72
  • Close
    61.70
  • Volume
    1,595,440

Financial ratios

Sep 30, 2024

Activity ratios
Inventory turnover
3.13
Receivables turnover
4.45
Payables turnover
12.42
Working capital turnover
0.93
Days of inventory on hand (DOH)
116.71
Days of sales outstanding (DSO)
82.02
Number of days of payables
29.39
Fixed asset turnover
1.48
Total asset turnover
0.51
 Liquidity ratios
Current ratio
8.20
Quick ratio
7.00
Cash ratio
5.50
Cash conversion cycle
169.34
 Solvency ratios
Debt-to-assets ratio
0.65
Debt-to-capital ratio
0.71
Debt-to-equity ratio
2.42
Financial leverage ratio
3.74
Interest coverage
1.09
 Profitability ratios
Gross profit margin
59.34%
Operating profit margin
7.84%
Pretax margin
8.51%
Net profit margin
8.14%
Operating return on assets (Operating ROA)
4.00%
Return on assets (ROA)
4.15%
Return on total capital
4.38%
Return on equity (ROE)
15.55%